HealthcareServices

Glycomics or Glycobiology Market Insights Report: Opportunities and Drivers 2030

February 27, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the glycomics or glycobiology market from 2026–2035 with trusted insights from The Business Research Company

How much is the Glycomics or Glycobiology Market valued at in 2026, and what valuation is forecast for 2030?

The scale of the glycomics or glycobiology market has seen rapid growth over recent years. This market is anticipated to expand from $2.13 billion in 2025 to $2.49 billion in 2026, achieving a compound annual growth rate (CAGR) of 17.1%. Factors contributing to this historical growth include advancements in carbohydrate chemistry, an uptick in life sciences research, increased academic research funding, initial biomolecule characterization efforts, and the progression of analytical instruments.

The glycomics or glycobiology market is projected to undergo substantial expansion in the upcoming years. Its valuation is anticipated to climb to $4.66 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 17.0%. This growth during the forecast interval can be attributed to the proliferation of precision medicine, heightened pharmaceutical research and development investments, the necessity for biomarker discovery, technological improvements in mass spectrometry, and an increase in translational research. Noteworthy trends for this period encompass the broadening of glycan-based biological investigations, greater utilization of glycomics in drug discovery processes, an escalating demand for advanced glycan analysis tools, the increasing incorporation of glycobiology into diagnostic applications, and expanded collaborations between academic institutions and industrial entities.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8749&type=smp

What Drivers Are Influencing The Growth Of The Glycomics or Glycobiology Market?

The anticipated expansion of the glycomics or glycobiology market is fueled by a rising need for pharmaceutical products. These products encompass medications and drugs designed for the diagnosis, prevention, treatment, or cure of illnesses and health conditions in both humans and animals. Glycomics and glycobiology play a crucial role in pharmaceutical advancement, offering understanding into disease processes, pinpointing therapeutic targets, and refining drug design and effectiveness across diverse medical ailments. As an illustration, in February 2024, the US-based non-profit organization, Personalized Medicine Coalition, reported that in 2023, the FDA sanctioned 16 novel personalized treatments for rare disease patients, an increase from six in 2022. Among these recently approved personalized treatments for 2023 were also seven cancer drugs and three for various other diseases and conditions. Consequently, the escalating demand for pharmaceutical products is significantly contributing to the expansion of the glycomics or glycobiology market.

How Is The Glycomics or Glycobiology Market Organized Into Various Segments?

The glycomics or glycobiology market covered in this report is segmented –

1) By Product: Enzymes, Kits, Reagents And Chemicals, Instruments, Carbohydrates

2) By Application: Drug Discovery And Development, Disease Diagnostics, Other Applications

3) By End-User: Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Clinical Laboratories

Subsegments:

1) By Enzymes: Glycosidases, Glycosyltransferases, Sialidases

2) By Kits: Glycan Analysis Kits, Glycobiology Research Kits

3) By Reagents And Chemicals: Monosaccharides, Oligosaccharides, Chemical Modifiers

4) By Instruments: Mass Spectrometers, Chromatography Systems, Imaging Systems

5) By Carbohydrates: Natural Carbohydrates, Synthetic Carbohydrates

What Industry Trends Are Transforming The Glycomics or Glycobiology Market?

Leading companies within the glycobiology market are prioritizing the development of innovative solutions, such as glycan-display platforms, to accelerate the discovery of carbohydrate-based therapeutics and vaccines. Glycan-display platforms are technologies that present diverse sugar molecules (glycans) on surfaces or scaffolds to investigate their interactions with proteins, cells, or pathogens for the purpose of drug and vaccine development. For instance, in October 2024, CD BioGlyco, a US-based biotechnology company, launched its Glycan Display Platform. This advanced, integrated glycan-display technology offers multiple modalities, including traditional glycan arrays, cell-based glycan display, neoglycolipid (NGL) display, liquid glycan arrays (LiGA), glyco-phage display, and de novo glycan display, supporting a wide range of glycobiology research applications such as drug discovery and glycan-protein interaction studies. The platform utilizes synthesized or natural glycans, immobilizing or presenting them on carriers like lipids, phage particles, or engineered cells, thereby enabling researchers to explore glycan binding properties in varied contexts (e.g., fluid versus immobilized, monovalent versus multivalent). These features allow for high-throughput screening, fine-tuned control over glycan density or presentation format, and offer greater physiological relevance when contrasted with traditional glycan microarrays, which typically immobilize glycans on rigid surfaces.

Who Are The Prominent Global Companies Shaping The Glycomics or Glycobiology Market Landscape?

Major companies operating in the glycomics or glycobiology market are Aligent Technologies Inc., Bruker Corporation, Merck Co. & KgaA, New England Biolabs Inc., Danaher Corporation, Shimadzu Corporation, ProZyme Inc., Takara Bio Inc., Asparia Glycomics SL, Lectenz Bio, Chemily Glycoscience LLC, Z Biotech LLC, RayBiotech Inc., Thermo Fisher Scientific Inc., Promega Corporation, Bio-Techne Corp., AMS Bio LLC, Ludger Ltd., CD BioGlyco Ltd., GlycoDiag SAS, Kode Biotech Limited, Glyxera GmBH, Glycomix Ltd., R&D Systems Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/glycomics-or-glycobiology-global-market-report

Which Region Is Projected To Lead The Glycomics or Glycobiology Market During The Forecast Period?

North America was the largest region in the glycomics or glycobiology market share in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the glycomics or glycobiology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Glycomics or Glycobiology Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=8749&type=smp

Browse Through More Reports Similar to the Global Glycomics or Glycobiology Market 2026, By The Business Research Company

Glyphosate Market Report 2026

https://www.thebusinessresearchcompany.com/report/glyphosate-global-market-report

Glycomic Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/glycomic-therapeutics-global-market-report

Glycol Market Report 2026

https://www.thebusinessresearchcompany.com/report/glycol-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795